Neuphoria Therapeutics Inc. (NEUP) stock
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
$2.28+0.01 (+0.44%)
Close on Nov 18, 2026Market cap $68.54KP/E –Yield –
Neuphoria Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Neuphoria Therapeutics
Neuphoria Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?